Champlain Investment Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Champlain Investment Partners's RGEN Position: Q3 2026 in Review
Champlain Investment Partners reduced its Repligen (RGEN) stake by 22% in Q3 2026, selling an estimated $11.3M and leaving 249,195 shares worth $47.9M. The position accounts for 1.65% of the portfolio, ranked #5.
Champlain Investment Partners first reported a position in RGEN in Q3 2022 and has held it in 17 quarters since. The position peaked at $222M in Q4 2024. 525 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- Champlain Investment Partners held 249,195 shares of Repligen worth $47.9M as of Q3 2026.
- Champlain Investment Partners sold 69,760 Repligen shares in Q3 2026, an estimated $11.3M.
- Repligen made up 1.65% of Champlain Investment Partners's portfolio in Q3 2026, its #5 holding.
- Champlain Investment Partners first reported a position in Repligen in Q3 2022 and has held it in 17 quarters since.
- Champlain Investment Partners's Repligen position peaked at $222M in Q4 2024.
- 525 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on Champlain Investment Partners's 13F filing for Q3 2026, filed 12 Nov 2026.